Pharmaron Beijing Market Cap

Pharmaron Beijing has a market cap or net worth of 55.17 billion as of August 15, 2025. Its market cap has increased by 60.56% in one year.

Market Cap

55.17B

Enterprise Value

59.39B

Revenue

13.62B

Ranking

n/a

PE Ratio

27.54

Stock Price

22.26

Market Cap Chart

Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 55.17B, an increase of 555.16%. That is a compound annual growth rate of 33.24%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	55.17B	23.90%
Dec 31, 2024	44.53B	-14.67%
Dec 29, 2023	52.19B	-40.01%
Dec 30, 2022	86.99B	-33.39%
Dec 31, 2021	130.60B	16.63%
Dec 31, 2020	111.98B	155.06%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines	266.94B
Hansoh Pharmaceutical Group Company	221.78B
JD Health International	175.53B
Innovent Biologics	166.99B
Akeso	147.38B
Sino Biopharmaceutical	139.86B
WuXi Biologics	125.45B
CSPC Pharmaceutical Group	119.48B

Market Cap Rankings